Brief: Mymd Pharmaceuticals Investment Company Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10 Million Doses Of Oral Covid-19 Vaccine To Be Commercialized In Southeast Asia
Dec 29 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS INVESTMENT COMPANY ORAVAX MEDICAL
SIGNS
COOPERATION AND PURCHASE AGREEMENT FOR INITIAL PRE-PURCHASE OF
10 MILLION DOSES OF ORAL COVID-19 VACCINE TO BE COMMERCIALIZED
IN SOUTHEAST ASIA
* MYMD PHARMACEUTICALS INC - ORAMED AND MYMD ARE CURRENTLY
EVALUATING SEVERAL OPTIONS WITH RESPECT TO THEIR INTEREST IN
ORAVAX
* MYMD PHARMACEUTICALS INC - OPTIONS INCLUDE A POTENTIAL
DISTRIBUTION OF ORAVAX SHARES TO BOTH ORAMED AND MYMD
SHAREHOLDERS
Source text for Eikon: ID:nBw9spdBya
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results